Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-10-01-2019
Volume2019 Supplement
Issue 5

Pharmaceutical Technology North America, APIs, Excipients, and Manufacturing 2019 Supplement (PDF)

Click the title above to open the Pharmaceutical Technology APIs, Excipients, and Manufacturing 2019 in an interactive PDF format.

External Link - PharmTech_NA_API_Supp2019_wm.pdf

Download Issue PDF
Articles in this issue
Proactive Evaluation of Possible Genotoxic Impurities During the Early Stages of Drug Development
Proactive Evaluation of Possible Genotoxic Impurities During the Early Stages of Drug Development
How Excipient Type Influences Self-Emulsifying Drug Delivery
How Excipient Type Influences Self-Emulsifying Drug Delivery
Advancements in Encapsulation Technology
Advancements in Encapsulation Technology
Perspectives on Quality Attributes of Drug Products Containing Nanomaterials
Perspectives on Quality Attributes of Drug Products Containing Nanomaterials
Additives and Processing Aids in Pharmaceutical Excipients
Additives and Processing Aids in Pharmaceutical Excipients
Planning a Successful API Procurement Strategy
Planning a Successful API Procurement Strategy
PharmTech-CPhI-Suppt-Cambrex-Fig-1-.jpg
Uncovering Hidden Risks in Solid-State API Properties
Market Dynamics Drive the Agenda for CPhI Worldwide
Market Dynamics Drive the Agenda for CPhI Worldwide
Pharmaceutical Technology North America, APIs, Excipients, and Manufacturing 2019 Supplement (PDF)

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content
Site Logo
August 2nd 2025

Accelerate drug development with innovative 360˚ CDMO and CRO solutions: A comprehensive guide to streamlining drug development and reducing time to market

Patheon
Drug Solutions Podcast: Sustainable Solutions for Biopharma
August 2nd 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
In this podcast episode, we discuss sustainable approaches to such equipment and materials as medical propellants, flow sensor technology, and walk-in chambers, plus the critical role of women in elevating and accelerating development in these areas.
Site Logo
August 2nd 2025

Value reimagined: Unlocking ROI and efficiency in drug development

Patheon
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
August 2nd 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Survey with blurred city abstract lights background | Image Credit: © Tierney - stock.adobe.com
August 2nd 2025

Survey: Impacts of Tariffs & Trade Policy on the Bio/pharmaceutical Industry

Christopher Cole
Help us get a better picture of how new tariffs and trade policy have impacted you and your organization.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 2nd 2025

FDA Changes Opioid Pain Medication Labeling Requirements

Susan Haigney
The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse and addiction.